vimarsana.com
Home
Live Updates
Can Fite BioPharma : Immediate Report of Meeting : comparemela.com
Can Fite BioPharma : Immediate Report of Meeting
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of...
Related Keywords
Washington ,
United States ,
Tel Aviv ,
Israel ,
Ramat Gan ,
Israeli ,
American ,
Pnina Fishman ,
Abraham Sartani ,
Yoseph Bornstein ,
Motti Farbstein ,
Kiryat Matalon ,
Kost Forer Gabbay Kasierer ,
Ilan Cohn ,
Securities Exchange ,
Israeli Securities Authority ,
American Depositary Shares Of The Company ,
Israeli Companies Law ,
Tel Aviv Stock Exchange ,
York Stock Exchange ,
New York Stock Exchange ,
Israel Companies Regulations Proof Of Ownership ,
Fite Biopharma Ltd ,
Company Compensation ,
Companies Law ,
Commission Public Reference Room ,
Exchange Commission ,
Commission File Number ,
Foreign Private Issuer Pursuant ,
Securities Exchange Act ,
Registration Statements ,
Can Fite Biopharma ,
Annual General Meeting ,
Gurion Street ,
Proxy Statement ,
Proxy Card ,
Voting Instruction Card ,
American Depositary Shares ,
Instruction Card ,
American Depositary Shareholders ,
Executive Officer ,
Chief Financial Officer ,
Can Fite Biopharma Ltd ,
General Meeting ,
Chief Executive ,
Compensation Policy ,
Kost Forer Gabbay ,
Young Global ,
Israel Companies Regulations ,
General Meetings ,
Chief Financial ,
American Depository Shares ,
Wednesday May ,
Deposit Agreement ,
New York Mellon ,
Record Shareholders ,
Beach Proposal ,
Proxy Materials ,
Annual Meeting ,
Exchange Act ,
Public Reference Room ,
Annual Report ,
Classi Directors ,
Classi Director ,
Guy Regev ,
comparemela.com © 2020. All Rights Reserved.